US Stock MarketDetailed Quotes
KHRNF KHIRON LIFE SCIENCES CORP
- 0.000001
- 0.0000000.00%
15min DelayClose Nov 25 16:00 ET
232.41Market Cap0.00P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.000001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)232.41MShares0.02000052wk High0.00P/B232.41Float Cap0.00000152wk Low--Dividend TTM232.41MShs Float0.480000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low--Avg Price1Lot Size
KHIRON LIFE SCIENCES CORP Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | (Q1)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q4)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.81%3.39M | 59.58%4.47M | 63.72%4.64M | 59.60%12.8M | 44.40%3.64M | 82.51%3.52M | 67.82%2.8M | 49.21%2.84M | -16.34%8.02M | 0.30%2.52M |
| Operating revenue | -3.81%3.39M | 59.58%4.47M | 63.72%4.64M | 59.60%12.8M | 44.40%3.64M | 82.51%3.52M | 67.82%2.8M | 49.21%2.84M | -16.34%8.02M | 0.30%2.52M |
| Cost of revenue | 1.52%1.73M | 116.77%2.12M | 146.90%3.15M | 536.67%6.42M | 216.58%2.47M | 70.78%1.71M | 47.81%978K | -12.89%1.28M | -85.88%1.01M | -244.63%-2.12M |
| Gross profit | -8.83%1.65M | 28.86%2.35M | -4.23%1.5M | -9.09%6.37M | -74.75%1.17M | 95.13%1.81M | 81.04%1.83M | 257.28%1.56M | 187.70%7.01M | 342.14%4.63M |
| Operating expense | -19.64%5.16M | -15.71%5.47M | -7.68%6.52M | -14.55%26.16M | -8.30%6.19M | -14.30%6.42M | -2.74%6.49M | -27.23%7.06M | -23.50%30.61M | -36.09%6.75M |
| Selling and administrative expenses | -20.79%4.61M | -27.83%4.45M | -13.34%5.62M | -15.56%23.99M | -13.11%5.53M | -17.56%5.82M | -3.97%6.17M | -24.39%6.48M | -20.90%28.41M | -33.41%6.36M |
| -Selling and marketing expense | -35.33%540K | 61.85%1.05M | 5.03%418K | 5.93%2.64M | 8.15%759K | 145.43%835K | -6.17%650K | -47.58%398K | -47.90%2.49M | -44.37%701.79K |
| -General and administrative expense | -18.35%4.07M | -38.40%3.4M | -14.54%5.2M | -17.62%21.35M | -15.75%4.77M | -25.82%4.98M | -3.70%5.52M | -22.14%6.09M | -16.74%25.91M | -31.74%5.66M |
| Research and development costs | -46.25%215K | 530.61%618K | 57.93%548K | -20.31%1.22M | 75.18%370K | 49.95%400K | -6.22%98K | -63.22%347K | -59.12%1.53M | -76.66%211.22K |
| Depreciation amortization depletion | 66.34%336K | 79.02%401K | 53.74%349K | 40.56%953K | 61.87%299K | 20.34%202K | 53.62%224K | 26.38%227K | 83.22%678K | 60.37%184.72K |
| -Depreciation and amortization | 66.34%336K | 79.02%401K | 53.74%349K | 40.56%953K | 61.87%299K | 20.34%202K | 53.62%224K | 26.38%227K | 83.22%678K | 60.37%184.72K |
| Operating profit | 23.89%-3.5M | 33.16%-3.12M | 8.66%-5.02M | 16.17%-19.79M | -136.85%-5.02M | 29.80%-4.6M | 17.67%-4.66M | 40.65%-5.5M | 37.19%-23.6M | 77.72%-2.12M |
| Net non-operating interest income expense | -24.00%-93K | 52.17%-33K | -63.16%-155K | 4.91%-445K | -206K | -75K | -69K | -95K | -468K | |
| Non-operating interest expense | 24.00%93K | -52.17%33K | 63.16%155K | -4.91%445K | --206K | --75K | --69K | --95K | --468K | ---- |
| Other net income (expense) | -89.05%147K | 1,391.78%943K | -365.93%-242K | -10,962.60%-13.36M | -4,683.53%-14.72M | 923.38%1.34M | -25.96%-73K | 298.30%91K | -89.96%123K | -75.46%321.22K |
| Gain on sale of security | -85.07%173K | 99,200.00%993K | -1,050.00%-437K | 6,342.86%1.31M | --104K | --1.16M | --1K | --46K | ---21K | ---- |
| Special income (charges) | -8,900.00%-88K | 107.89%6K | ---3K | ---15.21M | ---15.13M | --1K | ---76K | --0 | --0 | ---- |
| -Less:Impairment of capital assets | ---- | -107.89%-6K | ---- | --14.97M | ---- | ---- | --76K | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | --239K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Write off | 8,900.00%88K | ---- | --3K | ---- | ---- | ---1K | ---- | --0 | ---- | ---- |
| Other non- operating income (expenses) | -66.12%62K | -2,900.00%-56K | 340.00%198K | 270.14%533K | -11.46%303K | 212.20%183K | 103.45%2K | 96.96%45K | -89.52%144K | -73.85%342.22K |
| Income before tax | -3.45%-3.45M | 54.06%-2.21M | 1.51%-5.42M | -40.27%-33.59M | -779.40%-19.95M | 50.37%-3.34M | 16.05%-4.8M | 40.46%-5.5M | 34.12%-23.95M | 72.37%-2.27M |
| Income tax | 12,400.00%125K | -400.00%-35K | 14.29%-6K | -622.47%-465K | -528.82%-451K | 114.41%1K | 7.05%-7K | -311.04%-7K | 291.28%89K | 362.38%105.17K |
| Net income | -7.16%-3.58M | 54.72%-2.17M | 1.49%-5.41M | -37.81%-33.13M | -721.44%-19.5M | 50.31%-3.34M | 16.06%-4.8M | 40.52%-5.49M | 33.92%-24.04M | 71.17%-2.37M |
| Net income continuous Operations | -7.16%-3.58M | 54.72%-2.17M | 1.49%-5.41M | -37.81%-33.13M | -721.44%-19.5M | 50.31%-3.34M | 16.06%-4.8M | 40.52%-5.49M | 33.92%-24.04M | 71.17%-2.37M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -7.16%-3.58M | 54.73%-2.17M | 1.49%-5.41M | -37.81%-33.13M | -721.44%-19.5M | 50.31%-3.34M | 16.05%-4.8M | 40.52%-5.49M | 33.92%-24.04M | 71.17%-2.37M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -7.16%-3.58M | 54.73%-2.17M | 1.49%-5.41M | -37.81%-33.13M | -721.44%-19.5M | 50.31%-3.34M | 16.05%-4.8M | 40.52%-5.49M | 33.92%-24.04M | 71.17%-2.37M |
| Basic earnings per share | 0.00%-0.02 | 66.67%-0.01 | 25.00%-0.03 | 0.00%-0.2 | 71.79%-0.11 | -133.33%-0.02 | 40.00%-0.03 | 50.00%-0.04 | 44.44%-0.2 | -457.14%-0.39 |
| Diluted earnings per share | 0.00%-0.02 | 66.67%-0.01 | 25.00%-0.03 | 0.00%-0.2 | 71.79%-0.11 | -133.33%-0.02 | 40.00%-0.03 | 50.00%-0.04 | 44.44%-0.2 | -457.14%-0.39 |
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data